Prevalence of abnormal serum alanine aminotransferase levels in obese patients and patients with type 2 diabetes

被引:49
作者
Erbey, JR [1 ]
Silberman, C [1 ]
Lydick, E [1 ]
机构
[1] SmithKline Beecham Pharmaceut, Worldwide Epidemiol, Collegeville, PA 19426 USA
关键词
D O I
10.1016/S0002-9343(00)00602-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:588 / 590
页数:3
相关论文
共 10 条
[1]  
Creutzfeldt W, 1970, Prog Liver Dis, V3, P371
[2]  
EVERHART JE, 1995, DIABETES AM, P469
[3]   Severe hepatotoxicity associated with troglitazone [J].
Herrine, SK ;
Choudhary, C .
ANNALS OF INTERNAL MEDICINE, 1999, 130 (02) :163-164
[4]   Can comorbidity be measured by questionnaire rather than medical record review? [J].
Katz, JN ;
Chang, LC ;
Sangha, O ;
Fossel, AH ;
Bates, DW .
MEDICAL CARE, 1996, 34 (01) :73-84
[5]  
Kohlroser J, 2000, AM J GASTROENTEROL, V95, P272
[6]  
Meltzer AA, 1997, AM J EPIDEMIOL, V146, P565
[7]   THE PATHOLOGY OF DIABETIC HEPATITIS [J].
NAGORE, N ;
SCHEUER, PJ .
JOURNAL OF PATHOLOGY, 1988, 156 (02) :155-160
[8]   CLINICAL USE OF SERUM ENZYMES IN LIVER-DISEASE [J].
REICHLING, JJ ;
KAPLAN, MM .
DIGESTIVE DISEASES AND SCIENCES, 1988, 33 (12) :1601-1614
[9]   LIVER-FUNCTION TESTS IN DIABETIC-PATIENTS [J].
SALMELA, PI ;
SOTANIEMI, EA ;
NIEMI, M ;
MAENTAUSTA, O .
DIABETES CARE, 1984, 7 (03) :248-254
[10]  
SILVERMAN JF, 1989, PATHOL ANNU, V24, P275